Scarica l'app Stockscreener
25.55
6.72%
-1.89
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BEAM Giù?
Forum
Previsione
Beam Therapeutics Inc Borsa (BEAM) Ultime notizie
HC Wainwright Predicts Weaker Earnings for Beam Therapeutics - MarketBeat
JPMorgan Chase & Co. Trims Stock Position in Beam Therapeutics Inc. $BEAM - MarketBeat
ARK Investment Boosts Stake in Beam Therapeutics - National Today
Amova Asset Management Americas Inc. Buys 103,939 Shares of Beam Therapeutics Inc. $BEAM - MarketBeat
Beam Therapeutics Earnings Call Highlights PKU Pivot - TipRanks
What is HC Wainwright's Forecast for BEAM Q1 Earnings? - MarketBeat
Mintz Advises Sixth Street On $500 Million Strategic Financing Facility With Beam Therapeutics - Mondaq
Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU) - ADVFN Ltd
H.C. Wainwright reiterates Beam Therapeutics stock rating at buy By Investing.com - Investing.com Australia
H.C. Wainwright reiterates Beam Therapeutics stock rating at buy - Investing.com UK
Contrarius Group Holdings Ltd Buys Shares of 1,533,269 Beam Therapeutics Inc. $BEAM - MarketBeat
BEAM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Vanguard Group Inc. Sells 455,440 Shares of Beam Therapeutics Inc. $BEAM - MarketBeat
BEAM SEC FilingsBeam Therapeutics Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
BEAM.O PE Ratio & Valuation, Is BEAM.O Overvalued - Intellectia AI
RBC Capital Maintains a Sector Perform Rating on Beam Therapeutics (BEAM), Here’s Why - Yahoo Finance
Beam Therapeutics (NASDAQ:BEAM) Raised to Hold at Wall Street Zen - MarketBeat
BEAM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Should You Buy Beam Therapeutics Inc (BEAM) Today? Analysis, Price Targets, and 2026 Outlook. - Intellectia AI
Assessing Beam Therapeutics (BEAM) Valuation After Q4 Earnings Surprise Credit Facility And PKU Program Launch - simplywall.st
Beam Therapeutics: Great Potential, But Patience Is Needed (NASDAQ:BEAM) - Seeking Alpha
Beam Therapeutics reveals new program for PKU - bioworld.com
Bernstein SocGen cuts Beam Therapeutics stock price target on valuation By Investing.com - Investing.com Canada
Bernstein SocGen cuts Beam Therapeutics stock price target on valuation - Investing.com
Beam Therapeutics Clarifies Growth Path With PKU Program And New Financing - Yahoo Finance
Beam Therapeutics (BEAM) Quarterly Profit Surprises Loss Narrative With US$244.3 Million Net Income - simplywall.st
Beam Therapeutics (NASDAQ:BEAM) Trading Down 6.3%Time to Sell? - MarketBeat
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street - WilmerHale
BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y - Finviz
Beam Therapeutics (NASDAQ:BEAM) Price Target Raised to $26.00 - MarketBeat
BEAM Shares See Target Price Boost by RBC Capital | BEAM Stock N - GuruFocus
Beam Therapeutics Stock Surges 14% on Strategic Financing: How the $500M Agreement Secures a $156 Target - TIKR.com
Beam Therapeutics Opens with 7.83% Gain, Outperforming S&P 500's 0.69% Rise - Markets Mojo
Beam Therapeutics Hits Day High with 17.04% Surge in Stock Price - Markets Mojo
Wedbush Raises BEAM Price Target to $65, Maintains Outperform Ra - GuruFocus
Beam Therapeutics (NASDAQ:BEAM) Stock Price Expected to Rise, Wedbush Analyst Says - MarketBeat
Beam Therapeutics (BEAM) stock edges up premarket after 14% jump on results, $500 million facility - Bez Kabli
RBC Capital Adjusts Beam Therapeutics Price Target to $26 From $22, Maintains Sector PerformSpeculative Risk Rating - marketscreener.com
Beam Therapeutics Inc. (NASDAQ:BEAM) Q4 2025 Earnings Call Transcript - Insider Monkey
Mintz Advises Sixth Street on $500 Million Strategic Financing Facility with Beam Therapeutics - Mintz
Decoding Beam Therapeutics Inc (BEAM): A Strategic SWOT Insight - GuruFocus
Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring a 72.96% Potential Upside in the Biotech Innovator - DirectorsTalk Interviews
Beam Therapeutics Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Earnings Call Summary | Beam Therapeutics(BEAM.US) Q4 2025 Earnings Conference - 富途牛牛
[144] Beam Therapeutics Inc. SEC Filing - Stock Titan
BofA raises Beam Therapeutics stock price target on pipeline progress By Investing.com - Investing.com Australia
Beam Therapeutics Inc (BEAM) Q4 2025 Earnings Call Highlights: Strategic Financing and ... By GuruFocus - Investing.com Canada
Beam Therapeutics Inc (BEAM) Q4 2025 Earnings Call Highlights: S - GuruFocus
What's Going On With Beam Therapeutics Stock?Beam Therapeutics (NASDAQ:BEAM) - Benzinga
BofA raises Beam Therapeutics stock price target on pipeline progress - Investing.com
Beam Therapeutics Shares Rise After Swinging to Q4 Adjusted Earnings - marketscreener.com
Analyst bullish on Beam Therapeutics (BEAM) over drug program trajectory - MSN
Beam Therapeutics Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Beam Therapeutics Inc. announced that it expects to receive $500 million in funding - marketscreener.com
Wedbush Raises Beam Therapeutics Price Target to $65 From $57, Maintains Outperform Rating - marketscreener.com
Beam Therapeutics Q4 Earnings Call Highlights - MarketBeat
BEAM: BEAM-304 for PKU and $500M financing drive pipeline growth and extend cash runway into 2029 - TradingView
Beam Therapeutics (NASDAQ:BEAM) Shares Gap Up on Strong Earnings - MarketBeat
Beam Therapeutics Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:BEAM) 2026-02-24 - Seeking Alpha
Earnings call transcript: Beam Therapeutics sees stock rise after Q4 2025 updates - Investing.com
Beam Therapeutics Inc. Announces $500 Million Strategic Financing Facility with Sixth Street - marketscreener.com
Beam Therapeutics (BEAM) Surpasses Q4 Earnings Expectations - GuruFocus
Vestmark Advisory Solutions Inc. Sells 156,703 Shares of Beam Therapeutics Inc. $BEAM - MarketBeat
Beam Therapeutics Inc. (BEAM) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Beam Therapeutics (NASDAQ:BEAM) Posts Earnings Results - MarketBeat
Beam Therapeutics Secures Up to $500 Million Sixth Street Financing - marketscreener.com
Beam Therapeutics (BEAM) Secures $500 Million Funding for Sickle Cell Therapy - GuruFocus
Beam Therapeutics to Host Investor Webcast for Fourth Quarter and Year-End 2025 Financial Results and New Liver-targeted Genetic Disease Program - Sahm
BEAM Expands Genetic Medicine Pipeline with New PKU Program - GuruFocus
Beam Therapeutics Secures $500 Million Credit Facility - TipRanks
4.16%
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):